As of now, there is still no definitive cure for coronavirus and scientists are scrambling to find and develop a cure. Papua New Guinea is also on the search for a cure as its government has allocated $3 million to an unknown firm to find a possible COVID-19 cure.
Papua New Guinea has given $3 million to a company known as Niugini BioMed Ltd., which was established back in August. The funds will be used for research to discover a possible cure for COVID-19 from existing drugs. This report was found from leaked documents in contrast to Prime Minister James Marape saying that the country’s national executive council has not yet completed its approval process to assign a company to find a possible COVID-19 cure.
So far, a team from the University of Papua New Guinea was claimed to have looked through 30,000 known drugs all over the world to identify 10 possible COVID-19 treatments. The cabinet submission that presented the claim was also signed by Marape, will instruct the ministers, its treasury, and finance to give $10.2 million kinas or around $2.8 million. The submission also instructs its health department to collaborate with the company assigned to start running clinical trials.
“We have young and competent PNG scientists, who have presented their case to the COVID-19 controller...and our medical and science community, that they may be on to something big,” said Marape. “It may be true, or vice-versa, but I am not a prime minister to kill ingenuity, research, science, and study.”
Meanwhile, in the United States, a $375 million deal was brokered with company Eli Lilly to provide 300,000 doses of its experimental antibody drug to possibly treat COVID-19. The deal details that the company has two months to deliver the doses after being given an emergency use authorization by the Food and Drug Administration. It also gives the government an option to buy 650,000 more doses all the way through June 30, said the company.
Eli Lilly filed a request to the FDA this month for an emergency use authorization of its drug to be used on COVID-19 patients with mild to moderate cases.


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Neuralink Expands Brain Implant Trials with 12 Global Patients
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
U.S. Issues Cuba Health Alert as Illnesses Rise
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 



